Back
MiniMed Group, Inc.
Medical instruments & supplies
Company website ↗About
MiniMed Group is among the leading diabetes device manufacturers identified by Seagrove Partners and has the largest global footprint in its industry, operating in approximately 80 countries and serving more than 640,000 insulin pump users as of October 2025. According to Seagrove Partners’ November 2025 market model, Insulet, Tandem, Ypsomed, and Beta Bionics—companies MiniMed Group considers its closest insulin pump competitors—operate in 16, 23, 16, and one country, respectively.
MiniMed Group advances its mission through a well-invested, global, and experienced workforce of approximately 8,000 dedicated employees worldwide, including more than 3,000 commercial employees, supported by two world-class dedicated manufacturing facilities. Commercially and operationally, its scaled global infrastructure represents a significant barrier to entry, reflecting decades of operating experience outside the United States. Since 2001, MiniMed Group has produced more than five million insulin pumps. The company has extensive experience navigating diverse local regulatory and reimbursement frameworks and has made the substantial upfront investments required to establish a presence across its markets. In going to market, MiniMed Group promotes education in AID, expands access to its products in the United States across distribution channels and health plans, and differentiates itself outside the United States through participation in national tender regimes.
Headquarters
18000 Devonshire St. Northridge, CA 91325
Financial information
Underwriters
Goldman Sachs, BofA Securities, Citigroup, Morgan Stanley, Barclays, Deutsche Bank Securities, Mizuho, Wells Fargo Securities
Calls within Tajikistan are free
Investments
Information
The information provided is for informational purposes only and should not be considered as an offer to buy or sell foreign currency, securities and/or other financial instruments. The information presented on this website is not an individual investment recommendation. Financial instruments or transactions mentioned in this section may not be suitable for you, may not correspond to your investment profile, financial situation, investment experience, knowledge, investment objectives, attitude to risk and profitability.
LLC "Exchange Broker" does not guarantee and does not promise future profitability of investments, does not guarantee the reliability of possible investments and the stability of possible income. Investment results in the past do not guarantee income in the future.
LLC "Exchange Broker" is not responsible for possible investor losses in the event of transactions and investments in financial instruments, and also does not guarantee the return, effectiveness and profitability of investments.
LLC "Exchange Broker" hereby informs that it operates in the securities market in accordance with the following professional participant licenses issued by the Ministry of Finance of the Republic of Tajikistan: depository activity No.010/25 dated 25.06.2025; brokerage activity No.007/25 dated 25.06.2025; dealer activity No.008/25 dated 25.06.2025 and securities management activity No.009/25 dated 25.06.2025, and also informs about the risk of a conflict of interest, including as a result of combining various types of professional activity in the securities market.